Precision Neuroscience
Develops a brain-computer interface intended to help people with paralysis operate digital devices.
$250MSeries D
ParticipantKI
Korea Investment Partners
Activity from announced rounds
Activity in this selectionUnited States
Korea Investment Partners is the investment manager named in Q-Factor and BreezeBio financing histories.
Recorded funding activity
Q-Factor develops neutral-atom quantum computing. BreezeBio develops genetic medicines using non-viral nanoparticle delivery. The stored Precision Neuroscience relationship remains in draft rather than being published with the investor profile.
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $310M 2 disclosed · full round size, not this investor’s share